relugolix
FDA Approves Relugolix for Endometriosis Pain
The FDA relugolix as a once-daily therapy for the management of moderate to severe pain associated with ...
AUGUST 24, 2022
FDA Grants sNDA Extension to Investigational Endometriosis Pain Drug
The FDA extended the review period for relugolix for the management of moderate to severe pain associated with ...
MAY 19, 2022
Load more